We are monitoring the impact of COVID-19 on APAC HbA1c Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4946
Share on
Share on

APAC HbA1c Testing Market Research Report – Segmented By Type, Technology, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4946
Pages: 145

The size of the Asia Pacific HbA1c Testing market is anticipated to grow at 12.67% CAGR from 2021 to 2026. The Asia Pacific market was estimated to be valued at USD 326.74 Million in 2021 and is expected to reach USD 593.26 Million by 2026.

One of the major factors likely to accelerate the growth of the HbA1c testing in the APAC region is the increase in diabetes research organizations and associations. Furthermore, over the forecast period, an increase in crucial player initiatives and the prevalence of diabetes are likely to contribute to the market's growth. Furthermore, the rapid growth of medical tourism and increased demand for precise HbA1c level measurements are projected to propel the market forward. Moreover, the rise in the senior population and the influence of a sedentary lifestyle and an unhealthy diet are also predicted to fuel the expansion of the Asia Pacific HbA1c testing market.

During the forecast period, the rapid growth in product approvals and launches and incorporation of various technologies in HbA1c testing instruments are expected to provide substantial potential possibilities for the market. In addition, many companies in this region have implemented wellness programs that require employees to undergo routine medical testing to overall productivity and resource efficiency. These programs, in which an employee's diagnostic tests and, in some instances, some therapies are paid for, have significantly increased the testing volume of clinical laboratories, consequently raising market income.

However, the restricted indications of HbA1c tests, high test costs and strict reimbursement policies are projected to limit the growth of the HbA1c testing market in the APAC region, while the rise in accuracy concerns among the population could pose a hurdle to the market's growth. In addition, hemoglobin A1c testing in the lab is expensive and time consuming, which prevents patients from obtaining A1C testing.

This research report on the APAC HbA1c Testing market has been segmented and sub-segmented into the following categories.

By Technology:

  • Ion-Exchange HPCL             
  • Enzymatic Assay   
  • Affinity Binding Chromatography  
  • Turbidimetric Inhibition Immunoassay       
  • Other       

By Type:

  • Hand-Held Devices               
  • Bench Top Devices   

By End User:

  • Hospital    
  • Home Care              
  • Diagnostic laboratory          
  • Research Institutions

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Because of rapid expansion in healthcare facilities and rising per capita disposable incomes, Asia-Pacific is predicted to grow at a high growth rate during the forecast period. The market for HbA1c testing in the Asia Pacific is likely to see a quick increase in revenue creation as companies operating in the region place a greater emphasis on solid and strategic relationships. Local medical device companies invest in hemoglobin analyzers that provide quick and precise findings, which is seen as a potential growth driver for the APAC HbA1c testing market. The regional market is predicted to increase due to their increasing usage of modern diagnostic tools and technologies and strategic initiatives such as relationships and agreements by significant comsignificants. Due to improved healthcare infrastructure and rising per capita disposable expenditures, Asia-Pacific is expected to be the fastest-growing market.

The Asia Pacific HbA1c testing market is expected to develop the fastest. The predicted period's growth rate increases the number of diabetes laboratory tests and well-qualified healthcare workers such as diabetologists and clinicians due to the growing burden of diabetes. According to the International Diabetes Federation (IDF), by 2035, around 382 million people worldwide would have diabetes. Around 60% will live in Asia, with one-third in China. ARKRAY Factory Pinghu, Inc., primarily for the Chinese domestic market, conducted diabetes testing tools and in vitro diagnostic reagents in January 2018. Therefore, clinical items are projected to see greater demand in the rapidly growing Chinese market for medical products.

As of 2019, China is expected to show the most promising growth in this region. The Asia Pacific is projected to register the highest growth rate in the coming years owing to the growing cases of diabetes. Moreover, the low cost of healthcare in Asia counties is a key factor boosting medical tourism in the region, which in turn will aid the market growth

KEY MARKET PLAYERS:

Companies playing an influential role in the APAC HbA1c Testing market are Tran Biomedicals ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 Ion-Exchange HPCL             

                                5.1.3 Enzymatic Assay   

                                5.1.4 Affinity Binding Chromatography  

                                5.1.5 Turbidimetric Inhibition Immunoassay        

                                5.1.6 Other        

                                5.1.7 Y-o-Y Growth Analysis, By Technology        

                                5.1.8 Market Attractiveness Analysis, By Technology      

                                5.1.9 Market Share Analysis, By Technology        

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Hand Held Devices               

                                5.2.3 Bench Top Devices              

                                5.2.4 Y-o-Y Growth Analysis, By Type     

                                5.2.5 Market Attractiveness Analysis, By Type   

                                5.2.6 Market Share Analysis, By Type     

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospital    

                                5.3.3 Home Care              

                                5.3.4 Diagnostic laboratory          

                                5.3.5 Research Institution            

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7 Market Attractiveness Analysis, By End User           

                                5.3.8 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Type

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Type

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Type

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Transasia Biomedicals ltd.                     

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories                               

                8.3 Alere Inc.                     

                8.4 Arkray Inc.                  

                8.5 Bio-Rad Laboratories Inc.                      

                8.6 Danaher Corporation                             

                8.7 F. Hoffmann-La Roche Ltd.                  

                8.8 Siemens Healthcare                                

                8.9 Trinity Biotech plc.                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, by technology along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Hand Held Devices Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Bench Top Devices Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  5. "Asia Pacific Ion-Exchange High-performance Liquid Chromatography
  6. Market, By Region, From 2021 to 2026 (USD Million)"
  7. Asia Pacific Enzymatic Assay Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific Affinity Binding Chromatography  Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Turbidimetric Inhibition Immunoassay   Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Other Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)
  12. Asia Pacific Hospital Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Home Care Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Diagnostic laboratory Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia Pacific Research Institution Market, By Region, From 2021 to 2026 (USD Million)
  16. Japan HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  17. Japan HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  18. Japan HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)
  19. China HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  20. China HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  21. China HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)
  22. India HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  23. India HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  24. India HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)
  25. Australia HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  26. Australia HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  27. Australia HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)
  28. South Korea HbA1c Testing Market, By Type, From 2021 to 2026 (USD Million)
  29. South Korea HbA1c Testing Market, By Technology, From 2021 to 2026 (USD Million)
  30. South Korea HbA1c Testing Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample